M. Xue

发表

Functional mesenchymal stem cells remain present in bone marrow microenvironment of patients with leukemia post-allogeneic hematopoietic stem cell transplant

Yang Yang, Dong-Mei Han, Heng-Xiang Wang, 2014, Leukemia & lymphoma.

Functional mesenchymal stem cells remain present in the bone marrow microenvironment of leukemia patients post allogeneic hematopoietic stem cell transplantation

Yang Yang, Dong-Mei Han, Heng-Xiang Wang, 2013 .

A study of human leukocyte antigen‐haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients

N. Mao, Dong-Mei Han, H. Ning, 2020, Stem cells translational medicine.

Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity

N. Mao, Dong-Mei Han, H. Ning, 2020, Stem Cell Research & Therapy.

Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients

N. Mao, Dong-Mei Han, H. Ning, 2022, Bone Marrow Transplantation.

Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effects.

N. Mao, Dong-Mei Han, H. Ning, 2021, Cytotherapy.

[Effect of umbilical cord MSC infusion on the pulmonary infection in haploidentical hematopoietic stem cell transplantation].

Dong-Mei Han, Xiao-Li Zheng, Ling Zhu, 2014, Zhongguo shi yan xue ye xue za zhi.

Risk factors in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk childhood acute leukemia

Dong-Mei Han, Xiao-Li Zheng, Ling Zhu, 2017, International Journal of Hematology.

Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement

Zi-Kuan Guo, Ling Zhu, Zhi-dong Wang, 2009, Leukemia & lymphoma.

Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone.

Ling Zhu, Zhi-dong Wang, L. Ding, 2009, Leukemia research.

Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients

N. Mao, Dong-Mei Han, H. Ning, 2022, Bone Marrow Transplantation.

Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells.

Dong-Mei Han, Xiao-Li Zheng, Zi-Kuan Guo, 2013, Cytotherapy.

Successful desensitization of high level donor-specific anti-HLA antibody in patients with hematological diseases receiving haploidentical allografts

Dong-Mei Han, Hongmin Yan, Xiao-Li Zheng, 2022, Annals of Hematology.

Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion.

C. Xun, Ling Zhu, M. Xue, 2003, Experimental hematology.

Haploidentical hematopoietic stem cell transplantation in hematologic malignancies with G-CSF mobilized bone marrow plus peripheral blood stem cells grafts without T cell depletion: a single center report of 29 cases

Zi-Kuan Guo, Zhi-dong Wang, Hong-Min Yan, 2010, Leukemia & lymphoma.

G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia

C. Xun, J. Liu, M. Xue, 2002, Bone Marrow Transplantation.

[Clinical study on hematopoietic reconstitution in patients with leukemia by haploidentical bone marrow transplantation].

Ling Zhu, Hong-Min Yan, M. Xue, 2003, Zhongguo shi yan xue ye xue za zhi.

HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILD HEMATOLOGIC MALIGNANCIES WITH G-CSF-MOBILIZED MARROW GRAFTS WITHOUT T-CELL DEPLETION: A Single-Center Report of 45 Cases

Zi-Kuan Guo, Ling Zhu, Zhi-dong Wang, 2009, Pediatric hematology and oncology.

Co-transfusion of haplo-identical hematopoietic and mesenchymal stromal cells to treat a patient with severe aplastic.

Hongmin Yan, Zi-Kuan Guo, Zhi-dong Wang, 2010, Cytotherapy.

Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.

H. Chen, J. Liu, L. Zhou, 2001, Chinese medical journal.

Low-dose foscarnet preemptive therapy for cytomegalovirus viremia after haploidentical bone marrow transplantation.

Zi-Kuan Guo, Ling Zhu, M. Xue, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Co-infusion of mesenchymal stromal cells has no effect on relapse and infection in patients with leukemia undergoing haploidentical hematopoietic stem cell transplant

Dong-Mei Han, Xiao-Li Zheng, Ling Zhu, 2015, Leukemia & lymphoma.

Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity

N. Mao, Dong-Mei Han, H. Ning, 2020, Stem Cell Research & Therapy.